CVS Health

CVS selling generic competitor to EpiPen, at one-sixth the price

CVS selling generic competitor to EpiPen, at one-sixth the price

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the lifesaving allergy treatment was eviscerated before Congress because of its soaring cost to consumers.

The drugstore chain says it will charge $109.99 for a two-pack of the authorized generic version of Adrenaclick, a lesser-known treatment compared to EpiPen, which can cost more than $600.

CVS Health Corp., the nation's second-largest drugstore chain, says it cut the price of the generic version of Adrenaclick nearly in half. The lower price is now available at all CVS stores. The chain runs about 9,600 retail pharmacies in the United States,...

54°